Nutriband Outlines Key Achievements and Plans for 2025 with AVERSA Technology
Nutriband (NTRB) reveals key achievements and plans for 2025 with AVERSA technology, targeting significant revenue growth. Learn more about the company's progress and potential impact on the pharmaceutical industry.
This news matters as it highlights Nutriband's progress in developing abuse-deterrent transdermal technology, which could have a significant impact on the pharmaceutical industry. Investors and stakeholders should take note of the company's advancements and potential for revenue growth in 2025.